UCB, a global pharmaceutical company, needed to modernize its digital infrastructure to overcome challenges with legacy systems that slowed content publishing, limited scalability, and complicated regulatory reviews. To resolve these issues, UCB sought a headless MACH (Microservices, API-first, Cloud-native, and Headless) architecture to enable faster workflows, better collaboration, and improved user experiences.

Appnovation partnered with UCB to evaluate headless CMS platforms, conducting a thorough analysis of features, scalability, and integration capabilities. The team designed a MACH-based system to ensure flexibility and efficient content delivery while developing a cohesive design system to maintain consistent user experiences. A phased implementation plan was created to minimize disruptions, address compliance and security, and support UCB’s long-term goals. Appnovation continues to provide technical leadership and strategic consulting, ensuring the platform evolves to meet UCB’s needs.

Appnovation’s ongoing engagement has enabled UCB to make informed decisions about their digital infrastructure while advancing the development of a proof of concept (POC) for their new platform. The modernized system has streamlined workflows for faster updates and improved regulatory efficiency, reducing compliance times. The MACH-based architecture ensures scalability and future growth, providing a robust and adaptable infrastructure that keeps UCB competitive in a dynamic industry.

At Appnovation, our experts excel in modernizing digital infrastructures that enhance efficiency and scalability for the pharmaceutical industry. By leveraging cutting-edge technologies, we designed a MACH-based system for UCB, streamlining workflows, improving regulatory processes, and enabling future-ready digital operations. Discover how our expertise in digital transformation can help your organization drive innovation and create lasting value.